BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Luo SH, Chu JG, Huang H, Yao KC. Safety and efficacy of transjugular intrahepatic portosystemic shunt combined with palliative treatment in patients with hepatocellular carcinoma. World J Clin Cases 2019; 7(13): 1599-1610 [PMID: 31367619 DOI: 10.12998/wjcc.v7.i13.1599]
URL: https://www.wjgnet.com/1007-9327/full/v7/i13/1599.htm
Number Citing Articles
1
Huzheng Yan, Guobao Wang, Wenliang Zhu, Kai Feng, Wenke Zhu, Xuan Wu, Zhenkang Qiu, Guanyu Chen, Weiwei Jiang, Fujun Zhang, Fei Gao. Feasibility and clinical value of TIPS combined with subsequent antitumor treatment in HCC patients with refractory ascitesTranslational Oncology 2020; 13(12): 100864 doi: 10.1016/j.tranon.2020.100864
2
Huzheng Yan, Zhenkang Qiu, Zhanwang Xiang, Kai Feng, Mingsheng Huang, Fei Gao. TIPS improves outcomes in patients with HCC and symptomatic portal hypertension: a multi-institution experienceCancer Imaging 2022; 22(1) doi: 10.1186/s40644-022-00451-9
3
Hai-lin Lu, Fei-fei Xuan, Yao-chang Luo, Xiao Qin. Efficacy and safety of transjugular intrahepatic portosystemic shunt combined with transcatheter embolization/chemoembolization in hepatocellular carcinoma with portal hypertension and arterioportal shuntAbdominal Radiology 2021; 46(11): 5417 doi: 10.1007/s00261-021-03214-5